🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate azithromycin ocular conjunctiva concentrations 7 and 14 days af...
Status
Completed
Location
Multiple Locations
Start Date
2003-02
Trial ID
NCT00356772
Treatments Being Tested
To demonstrate the efficacy of T1225 1.5% eye drops, in comparison to refer...
Status
Completed
Location
Multiple Locations
Start Date
2004-05
Trial ID
NCT00357773
Treatments Being Tested
To assess in children the efficacy and safety of 2 dosing regimens of T1225...
Status
Completed
Location
Multiple Locations
Start Date
2004-01
Trial ID
NCT00356720
Treatments Being Tested
To compare the ocular tolerance, safety and ocular pharmacokinetics of 3 co...
Status
Completed
Location
Unité de Pharmacologie Clinique
Start Date
2002-02
Trial ID
NCT00357539
Treatments Being Tested
The primary objective of this study is to demonstrate the efficacy of T1225...
Status
Completed
Location
C.H.N.O des XV-XX
Start Date
2010-03
Trial ID
NCT01089608
Treatments Being Tested
To evaluate the ocular tolerance of T1225 1% and 1.5% eye drops versus vehi...
Status
Completed
Location
Multiple Locations
Start Date
2002-10
Trial ID
NCT00357383
Treatments Being Tested
To evaluate azithromycin tear concentrations after instillation of one drop...
Status
Completed
Location
Multiple Locations
Start Date
2002-05
Trial ID
NCT00356850
Treatments Being Tested
To compare the ocular tolerance, the safety and the ocular pharmacokinetics...
Status
Completed
Location
Multiple Locations
Start Date
2002-03
Trial ID
NCT00357292
Treatments Being Tested